A preventable cancer should not remain a persistent threat to women’s health.

Cervical cancer elimination is within reach, but effective vaccines and screening tests are only part of the solution. Their promise depends on access: people must be able to receive HPV vaccination, complete recommended screening, and obtain timely follow-up and treatment when needed. Yet these opportunities remain out of reach for many.

Understanding how we arrived at this opportunity, and the work still ahead, begins with the connection between human papillomavirus (HPV) and cervical cancer, and the discoveries that made HPV vaccination possible.

HPV Vaccines: A History of Discovery and Prevention

The development of HPV vaccines illustrates how scientific discovery can transform for cancer prevention. Research into the relationship between HPV and cervical cancer laid the foundation for vaccines that can prevent the infections responsible for nearly all cervical cancers.

That history is more than a series of scientific milestones. It explains how vaccination became a powerful tool for prevention and why ensuring access remains essential to realizing its promise.

Explore the history and legacy of HPV vaccines in the graphic below.

Vaccination is a critical part of prevention, but it is not the entire pathway. Screening, follow-up, and care each have a distinct role and the connections between them matter.

HPV vaccination helps prevent the infections that cause nearly all cervical cancers. Clear, trusted information and access to vaccination help people benefit from that protection.

Screening can identify risk and changes that require further evaluation, creating an opportunity to act before cancer develops or to detect disease earlier.

Follow-up connects a screening result to the next step. Patients need to receive their results, understand what they mean, and complete any recommended evaluation.

Care ensures that people who need treatment can obtain it. Timely access and coordination across providers help turn detection into action.

Together, these steps form a pathway from prevention to care. When vaccination is out of reach, screening is missed, or follow-up is delayed, that pathway can break down. Advancing elimination requires attention to both the science and the practical barriers that keep people from benefiting from it.

Learn More About Cervical Cancer and HPV

The Society for Translational Oncology offers educational resources to deepen understanding of cervical cancer prevention and care.